Read Summary

Lymphoma Rounds: Philadelphia

The Westin Philadelphia, at Liberty Place (click here for directions)
99 S. 17th Street
Philadelphia, PA 19103

Wednesday, April 3, 2019
6:00 PM – 8:30 PM


Anna Niewiarowska, MD
Vita Medical Associates, PC

Ubaldo Martinez-Outschoorn, MD
Thomas Jefferson University


This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, LRF, at  Exhibit opportunities are also available, however, space is limited.

Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Piper Harmon ( at least one week before the program to confirm their attendance. Otherwise, an exhibit table will not be guaranteed.


The Lymphoma Research Foundation’s Philadelphia Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the Philadelphia area.

At the conclusion of this educational activity, the participant should be better able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment and management.
  • Apply best practices for treating lymphoma patients.
  • Inform patients about potential clinical trial opportunities.
  • Establish a network of health care professionals who work with lymphoma patients.
Other dates in the 2018-19 Philadelphia Rounds series:

  • Wednesday, April 3, 2019

Philadelphia Lymphoma Rounds Steering Committee

Cooper University Hospital
Andres Ferber, MD
Fox Chase Cancer Center
Nadia Khan, MD
Hackensack University Medical Center
Tatyana Feldman, MD
Rutgers Cancer Institute of New Jersey
Andrew Evens, DO, MSc, FACP
Thomas Jefferson University
Ubaldo Martinez-Outschoorn, MD
University of Pennsylvania
Stephen Schuster, MD (chair)
Stefan Barta, MD, MS, MRCP (UK)
Vita Medical Associates, PC
Anna Niewiarowska, MD

Joint Providership Statement

This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.

Accreditation Statement

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education

This activity is supported by educational grants from:

AbbVie Inc., Celgene Corporation, Genentech, Novartis, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Seattle Genetics, Inc., TG Therapeutics, Inc. and Verastem Oncology

Print Friendly, PDF & Email